Mankind Pharma Ltd
Mankind Pharma Ltd. IPO Details: 4th Largest Pharma Co.
The Company was incorporated on July 3, 1991, as a private limited company under the Companies Act, 1956, with the name “Mankind Pharma Private Limited”, pursuant to a certificate of incorporation granted by the Registrar of Companies, Delhi and Haryana, at New Delhi (“RoC”). Pursuant to the conversion of the Company to a public limited company and as approved by the Shareholders pursuant to a special resolution dated July 14, 2005, the name of our Company was changed to “Mankind Pharma Limited” and the RoC issued a fresh certificate of incorporation on April 13, 2006.
Mankind Pharma Limited is India’s fourth largest pharmaceutical company in terms of
domestic sales and the third largest in terms of sales volume for MAT December 2022. It
engaged in developing, manufacturing and marketing a diverse range of pharmaceutical
formulations across various acute and chronic therapeutic areas, as well as several consumer
healthcare products. It focused on the domestic market, as a result of which the revenue from
operations in India contributed to 97.60% of its total revenue from operations for the Financial
Year 2022, which was one of the highest among peers identified by IQVIA. It has primarily
grown organically and is the youngest company among the five largest pharmaceutical
companies in India, in terms of Domestic Sales in 2022 (Source: IQVIA Dataset, Annual filings
/ company data).
Promoters: Ramesh Juneja, Rajeev Juneja & Sheetal Arora.
Managing Director: Rajeev Juneja.
| Issue Amount | Upto Rs 4,326 Crores |
| IPO Open Date | 25.04.2023 to 27.04.2023 |
| Face Value | Rs 1 Per Share |
| Price Band | Rs 1,026 to 1,080 |
| Lot Size | 13 Shares |
| Offer for Sale | Up to 4,00,58,844 Equity Shares |
| Offer Type | Book Built Offer |
| IPO Registrar | KFin Technologies Ltd. |
| Event | Tentative Date |
|---|---|
| IPO Open Date | 25 April 2023 |
| IPO Close Date | 27 April 2023 |
| Time | 10 AM to 5 PM |
| Basis of Allotment Date | 03 May 2023 |
| Initiation of Refunds | 04 May 2023 |
| Credit of Shares to Demat Account | 08 May 2023 |
| IPO Listing Date (Trading Commence) NSE & BSE | 09 May 2023 |
| Category | Allocation |
|---|---|
| Qualify Institutional Bidders (QIB) | 50% |
| Non Institutional Buyers (NIB) | 15% |
| Retail Individual Investor (RII) | 35% |
| Employee | – |
| Total | 100% |
(i) carry out the Offer for Sale of 40,058,844 Equity Shares by the Selling Shareholders aggregating to ₹ [●] million; and
(ii) achieve the benefits of listing the Equity Shares on the Stock Exchanges.
For the year/period ended (₹ in Crores) Last Three Year
| Particulars (in ₹ Crores) As per 31 March, | 2022 | 2021 | 2020 |
|---|---|---|---|
| Total Assets | 9,148 | 6,373 | 5,073 |
| Total Revenue | 7,782 | 6,214 | 5,865 |
| Net Profit & Loss For The Period After Tax | 1,433 | 1,265 | 1,030 |
Download RHP File
Download DRHP File
Pre Issue Share Holding: %
Post Issue Share Holding: %
Issue Amount : Upto Rs 4,326 Crore.
IPO is a main-board IPO. They are going to raise ₹ 4,326 Crores via IPO. The issue is priced at ₹ 1,026 to ₹ 1,080 per equity share. The IPO is to be listed on BSE & NSE.
25 April 2023 To 27 April 2023
The IPO is to open on 25/04/2023 for QIB, NII, and Retail Investors.
Mankind Pharma IPO Expected Returns is 10%.
Mankind Pharma IPO GMP is ₹ 90 as of today.
Registered Office: 208, Okhla Industrial Estate, Phase-III,
New Delhi 110 020, Delhi, India; Tel: +91 11 4747 6600
Corporate Office: 262, Okhla Industrial Estate, Phase-III,
New Delhi 110 020, Delhi, India; Tel: +91 11 4684 6700
Contact Person: Pradeep Chugh, Company Secretary and
Compliance Officer; Tel: +91 11 4684 6729
E-mail: investors@mankindpharma.com;
Website: www.mankindpharma.com;
Corporate Identity Number: U74899DL1991PLC044843
KFin Technologies Limited
Selenium, Tower B, Plot No. 31 and 32 Financial District,
Nanakramguda, Serilingampally, Hyderabad,
Rangareddi 500 032, Telangana, India
Tel: +91 40 6716 2222
E-mail: mankind.ipo@kfintech.com
Website: www.kfintech.com
Investor Grievance E-mail: einward.ris@kfintech.com
Contact Person: M Murali Krishna
SEBI Registration No: INR000000221
Zerodha customers can apply online in Mankind Pharma Limited IPO using UPI as a payment gateway. Zerodha customers can apply in Mankind Pharma Limited IPO by login into Zerodha Console (back office) and Select an I.P.O application form.
Steps to apply in Mankind Pharma Limited IPO through Zerodha.
1. Visit the Zerodha website or Kite App and login to Zerodha.
2. Go to Console area and click the IPOs link.
3. Go to the ‘Mankind Pharma Limited IPO’ row and click the ‘Bid’ button.
4. Enter your UPI ID, Quantity, and Price.
5. ‘Submit’ IPO application form.
6. After Successfully submitting application, Visit the UPI App and approve the mandate (Enter your UPI pin & pay the ipo amount)
7. IPO application is complete you can check status on zerodha console.
Click Here to Open Zerodha Account
How to Setup a Plant of Chapati Making Machine? Setting up a Chapati Making Machine Plant involves producing machines that… Read More
How to Setup a Manufacturing Plant of Ceramic Tiles? Setting up a Ceramic Tile Manufacturing Plant involves the production of… Read More
How to Setup a Manufacturing Plant of Ceramic Paints? Setting up a Ceramic Paints Manufacturing Plant involves producing specialized paints… Read More
How to Setup a Manufacturing Plant of Cement Grill? Setting up a Cement Grill Manufacturing Plant involves producing cement-based grills… Read More
How to Setup a Manufacturing Plant of Ceiling Fan? Setting up a Ceiling Fan Manufacturing Plant is a viable business… Read More
How to Setup a Manufacturing Plant of Cattle Feed? Setting up a Cattle Feed Manufacturing Plant is a profitable business,… Read More
This website uses cookies.